Japan, India, South Korea and Taiwan, who all export products to the US from these three industries, have already been stumbling under the pressure of increasing tariff threats

A fresh crackdown on the country's medical and pharmaceutical sectors, set to last a year, has convinced investors that it may be best to buy the state and sell private sector holdings